Seribantumab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Seribantumab, covering 2020-09-02 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors [Phase 2]